The Global NASH Council in the News

Pleased to share our new publication, “Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma” in Liver International, summarizing key advances presented at the First Annual Paris International Liver Meeting (PILM) 2026. The review highlights a fundamental shift in hepatology—from managing advanced disease and its complications toward earlier identification,...Continue reading→

One Spectrum, Not Three Silos: Rethinking Steatotic Liver Disease New review from the Global NASH/MASH Council (GNC) published in Nature Reviews Gastroenterology & Hepatology We are pleased to announce the publication of "The dynamic spectrum of steatotic liver disease: the global perspective" in Nature Reviews Gastroenterology & Hepatology. Led by Dr. Zobair M. Younossi and...Continue reading→

The Global NASH/MASH Council (GNC) and the Global Liver Council (GLC) are pleased to announce that 21 abstracts from our collaborative research programs have been accepted for presentation at The Liver Meeting 2026, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), taking place this November in Denver, Colorado. The...Continue reading→

The biannual meeting of the Global NASH/MASH Council (GNC) and the Global Liver Council (GLC), held in conjunction with EASL 2026 in Barcelona, Spain, convened over 60 leading hepatology experts from across the globe. The meeting was opened by Professor Zobair Younossi, Chair of the GNC/GLC, and was followed by a scientific program featuring distinguished...Continue reading→

Dear Colleagues, We are pleased to invite you to save the date for the Paris International Liver Meeting 2027, taking place January 21–23, 2027, at Maison de la Chimie in Paris, France. Building on the outstanding success of PILM 2026, which attracted 722 participants from 67 countries, we are excited to bring together the international...Continue reading→

Research by the Global NASH/MASH Council (GNC), led by Zobair M. Younossi, MD, has been published as the Cover Story of The Lancet Gastroenterology & Hepatology. Using National Health and Nutrition Examination Survey (NHANES) data spanning 1988–2023, the study demonstrates that alcohol consumption is underreported in population surveys, resulting in underestimation of alcohol-related liver disease...Continue reading→

Metabolic dysfunction-associated steatotic liver disease (MASLD) now affects more than one-third of the global adult population and has become an increasingly important driver of cirrhosis, hepatocellular carcinoma, liver transplantation, and liver-related mortality. The newly accepted global consensus recommendations in Clinical Gastroenterology and Hepatology (2026) provide a practical roadmap to help clinicians move from passive disease...Continue reading→

A new study shows that we have been underestimating alcohol related liver disease. Published this week in The Lancet Gastroenterology and Hepatology by members of the Global NASH MASH Council, this large US study using NHANES data from 1988 to 2023 and including 41,100 adults highlights a major issue. Underreporting alcohol use is leading to...Continue reading→

The 6th Annual Liver Connect Meeting of the Chronic Liver Disease Foundation was held from February 26–28, 2026, at the Gaylord Pacific Resort & Convention Center in beautiful San Diego, California. The meeting brought together more than 500 in-person attendees, along with a substantial number of virtual participants from across the country and internationally. The...Continue reading→